These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11712876)

  • 1. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
    Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Butcher M; Brant RF; Ghali WA; Bergqvist D; Raskob GE
    Ann Intern Med; 2001 Nov; 135(10):858-69. PubMed ID: 11712876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
    Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Ghali WA; Butcher MS; Brant RF; Bergqvist D; Hamulyák K; Francis CW; Marder VJ; Raskob GE
    Arch Intern Med; 2001 Sep; 161(16):1952-60. PubMed ID: 11525697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
    Gould MK; Dembitzer AD; Doyle RL; Hastie TJ; Garber AM
    Ann Intern Med; 1999 May; 130(10):800-9. PubMed ID: 10366369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.
    Heit JA; Elliott CG; Trowbridge AA; Morrey BF; Gent M; Hirsh J
    Ann Intern Med; 2000 Jun; 132(11):853-61. PubMed ID: 10836911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summaries for patients. Low-molecular-weight heparin given for several weeks after hip surgery prevents deep venous thrombosis.
    Ann Intern Med; 2001 Nov; 135(10):S-55. PubMed ID: 11757493
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
    Samama CM; Vray M; Barré J; Fiessinger JN; Rosencher N; Lecompte T; Potron G; Basile J; Hull R; Desmichels D;
    Arch Intern Med; 2002 Oct; 162(19):2191-6. PubMed ID: 12390061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
    Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
    Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
    Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
    J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?
    Strebel N; Prins M; Agnelli G; Büller HR
    Arch Intern Med; 2002 Jul; 162(13):1451-6. PubMed ID: 12090880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.